Anna Juncker-Jensen
San Clemente,CA
Summary
Driven leader with a proven track record at NeoGenomics, adept at spearheading scientific affairs with a flair for adopting new technologies and enhancing service offerings. Excelled in content development for scientific marketing, bolstering sales through innovative lead generation strategies. Skilled in fostering relationships with key opinion leaders, blending strong communication skills with expertise in scientific technical support.
Overview
15
15
years of professional experience
Work History
Senior Director, Head of Scientific Affairs
NeoGenomics
01.2017 - Current
- Lead a team of Scientific Affairs subject matter experts who provide advanced and relevant scientific and technical expertise as an integral part of NeoGenomics' Pharma Services Division.
- Drive adoption of new technology platforms, modalities, and service offerings.
- Support marketing initiatives by providing technical content for brochures, social media, and sales capabilities presentations.
- Develop lead generation strategies, including content marketing, and trade shows.
- Perform Pharma/Biotech pipeline analyses for sales presentations.
- Create and sustain relationships with academia and industry KOLs, and thought leaders.
- Support and execute R&D-focused projects and Pharma Services publication/scientific leadership strategy.
Senior Scientist
NantBioscience
01.2014 - 01.2017
- Company Overview: Drug Discovery Group
- Led a K-Ras project team responsible for the successful delivery of an optimized cancer drug candidate from hit optimization to the pre-clinical phase
- Developed, utilized, and validated cell-based high-throughput bioassays in support of oncology drug development programs
- Drug Discovery Group
Postdoctoral Researcher
Scripps Research Institute
La Jolla, CA
01.2010 - 01.2014
- Company Overview: Department of Cell & Molecular Biology
- Discovered a novel in vivo mechanism for MMP-1 promoting cancer intravasation
- Developed a novel orthotopic murine head and neck cancer metastasis model
- Department of Cell & Molecular Biology
Education
PhD - Cancer Cell Biology
The University of Copenhagen
01.2010
M.Sc. - Cancer Cell Biology
The University of Copenhagen
01.2007
Skills
- Leading and motivating teams to achieve organizational goals
- Content Development for Scientific Marketing
- Sales support and lead generation
- Strong written and verbal communication skills for presenting complex scientific content
Selected Publications
- Changes in the immune landscape of TNBC after neoadjuvant chemotherapy: correlation with relapse., MR Moamin, R Allen, SL Woods, JE Brown, H Nunns, A Juncker-Jensen, CE Lewis., Front Immunol, 11/09/23, 14, 1291643
- An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease., TJ Kendall, M Jimenez-Ramos, F Turner, P Ramachandran, J Minnier, MD McColgan, M Alam, H Ellis, DR Dunbar, G Kohnen, P Konanahalli, KA Oien, L Bandiera, F Menolascina, A Juncker-Jensen, et al., Nature Med, 11/01/23, 29, 11, 2939-2953
- Spatial relationship of tertiary lymphoid structures and tumor-associated neutrophils in bladder cancer and prognostic potential for anti-PD-L1 immunotherapy., X Wang & A Juncker-Jensen., Cancer Commun, 10/20/23
- Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy., Y Liu, J Yang, TS Hilliard, Z Wang, J Johnson, W Wang, EI Harper, C Ott, C O'Brien, L Campbell, B Crowley, S Grisoli, NM Stavrou, A Juncker-Jensen, MS Stack., J Exp Clin Cancer Res, 07/12/23, 42, 1, 165
- Compositions and methods of targeting mutant K-Ras., Co-authored U.S. patent (WO 2016161361 A1)., 10/06/16
- Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination., A Juncker-Jensen, EI Deryugina, I Rimann, E Zajac, TA Kupriyanova, LH Engelholm, JP Quigley., Cancer Res, 07/15/13, 73, 14, 4196-211
Phone - Number
858-729-8296
Languages
English
Native/ Bilingual
Danish
Native/ Bilingual
Spanish
Limited
French
Limited
German
Limited
Timeline
Senior Director, Head of Scientific Affairs
NeoGenomics
01.2017 - Current
Senior Scientist
NantBioscience
01.2014 - 01.2017
Postdoctoral Researcher
Scripps Research Institute
01.2010 - 01.2014
PhD - Cancer Cell Biology
The University of Copenhagen
M.Sc. - Cancer Cell Biology
The University of Copenhagen
Similar Profiles
Jackson DurhamJackson Durham
Client Services Lead at NeoGenomicsClient Services Lead at NeoGenomics
Damilola KadiriDamilola Kadiri
Cytogenetics Technologist at NeoGenomicsCytogenetics Technologist at NeoGenomics
Lester JunsayLester Junsay
Clinical Laboratory Technologist II - FISH at NeoGenomicsClinical Laboratory Technologist II - FISH at NeoGenomics